Contribute Try STAT+ Today

The Pharmalot View

Most Read

pill production line

The Pharmalot View By Ed Silverman

We shouldn’t rush to use an unproven malaria drug to treat the coronavirus

Alex Azar_2/26

The Pharmalot View By Ed Silverman

Azar has a ‘tin ear’ when it comes to pricing a potential coronavirus treatment

John Kapoor

The Pharmalot View By Ed Silverman

Kapoor certainly deserves to go to jail, but so do some other pharma execs

Dengvaxia

The Pharmalot View By Ed Silverman

Sanofi scandal in the Philippines could spread dangerous mistrust of vaccines

New Opioid Approved - Dsuvia

The Pharmalot View By Ed Silverman

The military pushed it for the battlefield. The FDA went along. Is the newest opioid any better?

Medicine

The Pharmalot View By Ed Silverman

Trump proposes importing medicines, but he’s really seeking a quick political hit

Vasant "Vas" Narasimhan

The Pharmalot View By Ed Silverman

Memo to the Novartis CEO: When in doubt, give the FDA a heads-up

Street lights

The Pharmalot View By Ed Silverman

If the states don’t treat pharma as a utility, it may be ‘lights out’ for too many patients

All Coverage

drugs

The Pharmalot View By Ed Silverman

FDA commissioner needs to push back and tell Trump the agency is not part of the ‘deep state’

HHS headquarters

The Pharmalot View By Ed Silverman

Operation Warp Speed doesn’t have the transparency it needs

remdesivir antiviral drug

The Pharmalot View By Ed Silverman

Where’s the data? In a pandemic, now is no time to sit on Covid-19 trial results

Scott Gottlieb

The Pharmalot View By Ed Silverman

The FDA commissioner sweepstakes: Is Azar yearning to get out of Gottlieb’s shadow?

Retro television

The Pharmalot View By Ed Silverman

Grandstanding, not real change: Why drug prices in TV ads will be confusing and irrelevant

Earth's City Lights at Night

The Pharmalot View By Ed Silverman

Forget about an international pricing index for drugs. Cost-effectiveness is a better bargain

Gottlieb vote

The Pharmalot View By Ed Silverman

Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator

The capitol at sunrise

The Pharmalot View By Ed Silverman

Prepare for grilling: 7 questions for 7 pharma execs who’ll testify before Congress about prices

Trump drug prices

The Pharmalot View By Ed Silverman

The list price is not right: Trump’s plan to force pharma to advertise prices is misguided

GSK - best exterior

The Pharmalot View By Ed Silverman

One of the world’s largest drug makers is paying docs again — and patients are the worse off

Alex Gorsky

The Pharmalot View By Ed Silverman

From zero to hero: J&J CEO praises Trump one year after chastising him

A photo of Pascal Soriot.

The Pharmalot View By Ed Silverman

When modest is actually excessive: AstraZeneca spins its price hikes

President Trump Delivers Remarks On Lowering Drug Prices In Rose Garden

The Pharmalot View By Ed Silverman

He can shame Pfizer and others, but Trump doesn’t have a practical way to lower drug prices

The Pharmalot View By Ed Silverman

Novartis’ tone-deaf response to Michael Cohen: troubling, but not surprising

Soldiers silhouette

The Pharmalot View By Ed Silverman

The Pentagon wants to approve drugs for the battlefield. Here’s why that’s dangerous

Jerry Brown

The Pharmalot View By Ed Silverman

California just passed a law to rein in drug prices. Here’s why it’s unlikely to make much difference

Dollars

The Pharmalot View By Ed Silverman

Here’s how a loophole in a transparency law can distort medical practices

The Pharmalot View By Ed Silverman

This pharma CEO won praise for his ‘social contract’ with the public. But his latest move could shred that pledge

Novartis campus

The Pharmalot View By Ed Silverman

At $475,000, new cancer drug raises thorny questions about drug pricing — and value

The Pharmalot View By Ed Silverman

Drug makers deserve to be publicly shamed for thwarting competition from generics

Handshake

The Pharmalot View By Ed Silverman

The art of the deal? Why a money-back guarantee for drugs is a bad idea

Donald Trump

The Pharmalot View By Ed Silverman

If drug companies are really ‘getting away with murder,’ Trump may be about to grant them a pardon

Supplements

The Pharmalot View By Ed Silverman

It’s time to make it legal for Americans to order prescription drugs from abroad

Aedes aegypti mosquitoes

The Pharmalot View By Ed Silverman

US taxpayers are funding a Zika vaccine. Let’s make sure US patients can afford it